Brief: Krystal Biotech Announces FDA Approval Of Updated VYJUVEK Label
15/09/2025 13:01
Sept 15 (Reuters) - Krystal Biotech Inc KRYS.O: KRYSTAL BIOTECH ANNOUNCES FDA APPROVAL OF UPDATED VYJUVEK® LABEL Source text: ID:nGNX11FVty Further company coverage: KRYS.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Krystal Biotech
See all newsBrief: Krystal Biotech Announces Positive Clinical Data For New Dermatology Program KB113 Demonstrating Broad Basal Cell Carcinoma Regression In Patients With Gorlin Syndrome
Krystal Biotech Inc reports results for the quarter ended June 30 - Earnings Summary
Krystal Biotech Q2 revenue rises on VYJUVEK strength
Brief: Krystal Biotech - Files Response With Uspto On Kb801 Patent Application - SEC Filing
Construction firm Tutor Perini jumps on S&P SmallCap inclusion